All In MedTech

Device Trial Radar · NCT05907564

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

Evaluate the Safety and Efficacy of the Aventus Thrombectomy System for Aspiration Thrombectomy in Subjects With Acute Pulmonary Embolism

Last checked: Nov 20, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registry

Status

Active, not recruiting

Enrollment

120

Actual

Start

Sep 20, 2023

Primary completion

Feb 20, 2025

Study completion Feb 2027

Sponsor

Lead sponsor
Inquis Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 18, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.

Conditions

  • Pulmonary Embolism
  • Embolism
  • Embolism and Thrombosis
  • Vascular Diseases
  • Cardiovascular Diseases
  • Lung Diseases
  • Respiratory Tract Diseases

Interventions

  • ThrombectomyDevice

    Use of Aventus Thrombectomy System to treat pulmonary embolism

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in RV/LV RatioTime frame: at 48hrs compared to baseline

1 more outcomes with a free account

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • Honor Health

    Scottsdale, Arizona

25 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.